• Eurofins Scientific CFO Laurent Lebras exercised 3,000 stock options on October 22, 2026, according to an October 26 disclosure.
• Related share sales included 1,000 shares at EUR 82 on October 22, totaling EUR 82,000.
• A further 2,000 shares sold at EUR 84 on October 23 generated EUR 168,000.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eurofins Scientific SE published the original content used to generate this news brief on October 26, 2026, and is solely responsible for the information contained therein.